Based in Clermont-Ferrand, this family-owned company has continued to expand by opening more than 30 affiliates and offices in Europe, Russia, North Africa, North and South America. Its products are available in more than 70 countries.
The strategy of Laboratoires Théa in R&D is focused on innovative drug delivery systems, the development of new molecules for ophthalmic use and the improvement of existing products through galenic development.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze